FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/31/2025
Back to search
Official data from USPTO
BDC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 42
Filing date
12/19/2023
Registration date
04/01/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/01/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
ANDREACCHI, SAMANTHA ALEXIS
Law office
O30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Bicycletx Limited
Representatives
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in oncology for both solid and liquid tumorsmetabolic diseaseurology and renal diseasecardiovascularhematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseasebacterial and viral infectious diseaseneurological and psychiatric disorders; pharmaceutical preparations for suppressing tumors; pharmaceutical products for the treatment of cancer; pharmaceutical products and preparations for use in the treatment and prevention of disease in the field of oncology; pharmaceutical products and preparations for use in the treatment and prevention of disease in the field of ophthalmology; pharmaceutical preparations for use in the treatment and prevention of disease in the field of neurology; anti-infective pharmaceutical preparations for use in preventing and treating infections; pharmaceutical products and preparations for the treatment of respiratory disease; pharmaceutical preparations for the treatment and prevention of cardiovascular disease; pharmaceutical preparations for the treatment and prevention of metabolic disease; pharmaceutical products and preparations for the treatment and prevention of viral infections; pharmaceutical preparations for use in medical diagnostics and imaging; pharmaceutical preparations for the treatment and prevention of renal disease; pharmaceutical preparations for the treatment and prevention of gastrointestinal disease; pharmaceutical preparations for the treatment and prevention of muscular skeletal disease
Class 42
Scientific and technological services and research and design relating theretoscientific research and new product design services in the fields of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumorsmetabolic diseaseurology and renal diseasecardiovascularhematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseasebacterial and viral infectious diseaseneurological and psychiatric disordersdiagnostic preparations and clinical imaging agents; medical research servicesindustrial analysis and research services in the field of medicine; research and development services in the field of pharmaceutical preparations; medical research services; pharmaceutical research servicespharmaceutical testing and clinical trials; scientific research in the nature of conducting clinical trials for others; research and development in the field of oncology; research and development in the field of ophthalmology; research and development in the field of neurology; research and development in the field of anti-infective pharmaceuticals; research and development in the field of respiratory disease; research and development in the field of cardiovascular disease; research and development in the field of metabolic disease; research and development in the field of antiviral drugs; research and development in the field of diagnostics and imaging; research and development in the field of renal disease; research and development in the field of gastrointestinal disease; research and development in the field of muscular skeletal disease; scientific research consultingproviding information consultancy and advisory services relating to the aforesaid in the fields of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumorsmetabolic diseaseurology and renal diseasecardiovascularhematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseasebacterial and viral infectious diseaseneurological and psychiatric disordersdiagnostic preparations and clinical imaging agents
Publications
History of USPTO decisions and trademark events.
35 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/14/2025
FIMP
FINAL DISPOSITION PROCESSED
10/14/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/19/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/03/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/03/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/02/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/01/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
04/01/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/26/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/26/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/26/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/26/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/26/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/26/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/11/2025
PUBO
PUBLISHED FOR OPPOSITION
02/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/05/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/23/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
01/21/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/21/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
01/21/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/21/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/16/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/16/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/16/2024
RFNT
REFUSAL PROCESSED BY IB
08/17/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/30/2024
RFRR
REFUSAL PROCESSED BY MPU
07/30/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/03/2024
CNRT
NON-FINAL ACTION WRITTEN
07/02/2024
DOCK
ASSIGNED TO EXAMINER
07/01/2024
MAFR
APPLICATION FILING RECEIPT MAILED
04/18/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/12/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/04/2024
Continuous trademark protection
Get notified about every new filing that threatens BDC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.